U.S. Markets open in 8 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 13.60 01:04 PM EST | |
|---|---|---|
| Day High | 14.38 10:00 AM EST |
|
| Range | 0.78 |
| Volume | 827,009 | |
|---|---|---|
| 30-Day Avg Vol | 2.18 M |
|
| Difference | -62.19% |
| Market Cap | 856.54 M | |
|---|---|---|
| Mkt Cap Chg | 2.46 M |
| Shares Out | 61.62 M | |
|---|---|---|
| % Shrs Traded | 1.34% | |
| 1yr EPS Est | -1.103 |
| 52-Wk Low | 2.9798 | |
|---|---|---|
| 52-Wk High | 16.62 |
|
| Range | 13.64 |
| Prev Close | 13.86 11/5/09 | |
|---|---|---|
| Today's Open | 13.75 | |
| Change | -0.79% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 10.75 M |
| Revenue (LFY) | 3.02 M | |
|---|---|---|
| Earnings (LFY) | -84.17 M | |
| Earnings (MRQ) | -54.81 M | |
| Next Earn Est | -0.287 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | -2.14 | |
| 1yr EPS Growth | 45.12% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -12.00 | |
| PEG Ratio | — | |
| Return on Equity | -83.74 | |
| Beta | 2.41 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Savient Pharmaceuticals aims to plump up the thin and send pesky urate crystals packing. The biopharmaceutical company is focused on two conditions: involuntary weight loss and gout. Its sole marketed ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.287 2/22/10 | — — |
—
—
|
| Last Quarter | -0.306 9/30/09 | -0.23 9/30/09 |
0.076
Beat
|
| 2 Quarters Ago | -0.388 6/30/09 | -0.92 6/30/09 |
-0.532
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 680,000.00 | 3.03 M |
| Gross Profit | 308,000.00 | 1.87 M |
| Operating Income | -17.73 M | -83.36 M |
| Net Income | -54.81 M | -84.17 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts